Virtus ETF Advisers LLC Arbutus Biopharma Corp Transaction History

Virtus ETF Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$1.9 - $2.27 $7,569 - $9,043	-3,984 Reduced 9.05%	40,040 $81,000
Q2 2023 Aug 14, 2023	BUY	$2.24 - $3.06 $15,292 - $20,890	6,827 Added 18.35%	44,024 $101,000
Q1 2023 May 15, 2023	SELL	$2.23 - $3.1 $31,886 - $44,326	-14,299 Reduced 27.77%	37,197 $112,000
Q4 2022 Feb 14, 2023	BUY	$1.91 - $2.85 $16,250 - $24,247	8,508 Added 19.79%	51,496 $119,000
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $588 - $901	313 Added 0.73%	42,988 $82,000

Q2 2022 Aug 12, 2022	BUY	$1.98 - $3.17 $10,349 - $16,569	5,227 Added 13.96%	42,675 $116,000
Q1 2022 May 16, 2022	SELL	$2.42 - $3.98 $5,389 - $8,863	-2,227 Reduced 5.61%	37,448 $112,000
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $123,389 - $182,901	39,675 New	39,675 $154,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.